Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7473 p395
13 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


New “orange book” advises on drug dependence

New clinical guidelines on the management of drug misuse and dependence have been published by the National Treatment Agency for Substance Misuse (NTA) on behalf of the UK health departments.

The updated “orange book”, for which a draft version was released for consultation earlier in the year (PJ, 23 June, p726), takes into account changes that have occurred in drug misuse treatment since the guidelines were first produced in 1999, as well as National Institute for Health and Clinical Excellence guidance.

The document looks at aspects of communication between prescribers and pharmacists providing a service for drug misusers. Pharmacists’ role in supervised consumption services is also covered.

Heather Walker, chief pharmacist, North East London Mental Health Trust, was a member of the working group for developing the guidelines. She told The Journal that the document promotes the value of pharmacists within shared care arrangements for drug dependence.

“Pharmacists can make important contributions in the treatment of drug misusers if they are kept in the loop,” she added.

She also drew attention to an annexe to the document, which describes requirements for writing Controlled Drug prescriptions for the treatment of drug dependence to be dispensed by a community pharmacist.

Drug misuse and dependence: UK guidelines on clinical management” is available online.

The NTA and NICE are running a series of one-day events to provide information on the new orange book and NICE’s clinical guidance.

Further information is available online

Mental health The National Institute for Mental Health in England’s National Workforce Programme has produced a best practice guide to help health and social care organisations implement new ways of working in mental health. The programme aims to expand multidisciplinary roles within the mental health workforce to improve patient care (PJ, 19 May, p578).

New ways of working for everyone: a best practice implementation guide” is available from the Department of Health website.

Back to Top


©The Pharmaceutical Journal